Mantle Cell Lymphoma

>

Latest News

Acalabrutinib Combo Improves PFS Over Standard of Care in Mantle Cell Lymphoma
Acalabrutinib Combo Improves PFS Over Standard of Care in Mantle Cell Lymphoma

May 2nd 2024

Acalabrutinib plus bendamustine and rituximab bettered progression-free survival over bendamustine and rituximab alone in patients with untreated mantle cell lymphoma.

Early MRD Guides Therapy in Mantle Cell Lymphoma
Early MRD Guides Therapy in Mantle Cell Lymphoma

March 22nd 2024

What Is High-Risk Mantle Cell Lymphoma, and How Should We Treat It?
What Is High-Risk Mantle Cell Lymphoma, and How Should We Treat It?

February 26th 2024

Liso-cel Appears Effective in High-Risk Patients With MCL
Liso-cel Appears Effective in High-Risk Patients With MCL

February 22nd 2024

SYMPATICO Trial of Ibrutinib Plus Venetoclax Boosts PFS in MCL
SYMPATICO Trial of Ibrutinib Plus Venetoclax Boosts PFS in MCL

January 29th 2024